These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 15368601

  • 1. Somatic characteristics and cardiovascular risk factors in growth hormone deficiency: a randomized, double-blind, placebo-controlled study of the effect of treatment with recombinant human growth hormone.
    Bell W, Davies JS, Evans WD, Scanlon MF, Mullen R.
    Am J Hum Biol; 2004; 16(5):533-43. PubMed ID: 15368601
    [Abstract] [Full Text] [Related]

  • 2. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
    Chihara K, Kato Y, Kohno H, Takano K, Tanaka T, Teramoto A, Shimatsu A.
    Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
    [Abstract] [Full Text] [Related]

  • 3. The effect of growth hormone substitution on cognitive performance in adult patients with hypopituitarism.
    Oertel H, Schneider HJ, Stalla GK, Holsboer F, Zihl J.
    Psychoneuroendocrinology; 2004 Aug; 29(7):839-50. PubMed ID: 15177699
    [Abstract] [Full Text] [Related]

  • 4. Effect of recombinant human growth hormone on exercise capacity in patients with HIV-associated wasting on HAART.
    Evans WJ, Kotler DP, Staszewski S, Griffin GE, Isgaard J, Gertner JM, O'Brien F, Svanberg E.
    AIDS Read; 2005 Jun; 15(6):301-3, 306-8, 310, 314. PubMed ID: 15962453
    [Abstract] [Full Text] [Related]

  • 5. What are the clinical benefits of correcting the catabolic state in haemodialysis patients?
    Jensen PB, Hansen TB, Oxhøj H, Froberg K, Ekelund B, Nielsen FT, Pedersen FB.
    Br J Clin Pract Suppl; 1996 Aug; 85():47-51. PubMed ID: 8995031
    [Abstract] [Full Text] [Related]

  • 6. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
    Fideleff HL, Boquete HR, Stalldecker G, Giaccio AV, Sobrado PG.
    Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
    [Abstract] [Full Text] [Related]

  • 7. Gender differences in growth hormone response to exercise before and after rhGH administration and the effect of rhGH on the hormone profile of fit normal adults.
    Giannoulis MG, Boroujerdi MA, Powrie J, Dall R, Napoli R, Ehrnborg C, Pentecost C, Cittadini A, Jørgensen JO, Sonksen PH, GH-2000 Study Group.
    Clin Endocrinol (Oxf); 2005 Mar; 62(3):315-22. PubMed ID: 15730413
    [Abstract] [Full Text] [Related]

  • 8. Growth hormone treatment and fat redistribution in children born small for gestational age.
    De Schepper J, Thomas M, Beckers D, Craen M, Maes M, de Zegher F.
    J Pediatr; 2008 Mar; 152(3):327-30. PubMed ID: 18280835
    [Abstract] [Full Text] [Related]

  • 9. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
    Albert SG, Haas MJ, Mooradian AD.
    Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
    [Abstract] [Full Text] [Related]

  • 10. Evidence for a decrease in cardiovascular risk factors following recombinant growth hormone administration in abstinent anabolic-androgenic steroid users.
    Graham MR, Baker JS, Evans P, Kicman A, Cowan D, Hullin D, Davies B.
    Growth Horm IGF Res; 2007 Jun; 17(3):201-9. PubMed ID: 17324600
    [Abstract] [Full Text] [Related]

  • 11. Effects of postmenopausal hormone replacement therapy on body fat composition.
    Yüksel H, Odabasi AR, Demircan S, Köseoğlu K, Kizilkaya K, Onur E.
    Gynecol Endocrinol; 2007 Feb; 23(2):99-104. PubMed ID: 17454160
    [Abstract] [Full Text] [Related]

  • 12. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency.
    Salomon F, Cuneo RC, Hesp R, Sönksen PH.
    N Engl J Med; 1989 Dec 28; 321(26):1797-803. PubMed ID: 2687691
    [Abstract] [Full Text] [Related]

  • 13. Recombinant human growth hormone, but not insulin-like growth factor-I, enhances central fat loss in postmenopausal women undergoing a diet and exercise program.
    Taaffe DR, Thompson JL, Butterfield GE, Hoffman AR, Marcus R.
    Horm Metab Res; 2001 Mar 28; 33(3):156-62. PubMed ID: 11355749
    [Abstract] [Full Text] [Related]

  • 14. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
    Esen I, Demirel F, Tepe D, Kara O, Koc N.
    Growth Horm IGF Res; 2013 Oct 28; 23(5):196-9. PubMed ID: 23890535
    [Abstract] [Full Text] [Related]

  • 15. Effects of a combination of rhGH and metformin on adiponectin levels in patients with metabolic syndrome.
    Herrmann BL, Saller B, Stratmann M, Berg C, Mann K, Janssen OE.
    Horm Metab Res; 2005 Jan 28; 37(1):49-52. PubMed ID: 15702440
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 28; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 17. Head circumference in chronic renal failure from birth.
    Van Dyck M, Proesmans W.
    Clin Nephrol; 2001 Dec 28; 56(6):S13-6. PubMed ID: 11770805
    [Abstract] [Full Text] [Related]

  • 18. [Severely burned patients after surgery: recombinant human growth hormone therapy its metabolic effects].
    Chai J, Hao D, Wu Y, Shen C, Guo Z, Sheng Z.
    Zhonghua Wai Ke Za Zhi; 2002 Feb 28; 40(2):107-11. PubMed ID: 11955392
    [Abstract] [Full Text] [Related]

  • 19. Effect of 6 months of exercise and isoflavone supplementation on clinical cardiovascular risk factors in obese postmenopausal women: a randomized, double-blind study.
    Aubertin-Leheudre M, Lord C, Khalil A, Dionne IJ.
    Menopause; 2007 Feb 28; 14(4):624-9. PubMed ID: 17290158
    [Abstract] [Full Text] [Related]

  • 20. Comparison of metabolic effects of orlistat and sibutramine treatment in Type 2 diabetic obese patients.
    Derosa G, Cicero AF, Murdolo G, Ciccarelli L, Fogari R.
    Diabetes Nutr Metab; 2004 Aug 28; 17(4):222-9. PubMed ID: 15575343
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.